Please assess the completion status of the following clinical trial:

Trial Title: Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Planned diagnostic coronary or peripheral artery angiography~* T2DM~* CKD stages 2 and 3, eGFR 30 to 89ml/min per 1.73m2~* Statin naive, or not on statin treatment for at least 14 days~* Withdrawal metformin or aminophylline for 48h before angiography~* Total iodixanol volume~Exclusion Criteria:~* Hypersensitivity to iodine-containing compounds and statins~* Type 1 diabetes mellitus~* Ketoacidosis~* Lactic acidosis~* CKD stages 1,4 or 5 (eGFR≥90ml/min per 1.73m2 or eGFR\<30ml/min per 1.73m2)~* STEMI~* NYHA class IV or hemodynamic instability~* Administration of any iodinated CM within 14 days before randomization~* LDL-C\<1.82mmol/L（70mg/dL）~* Hepatic dysfunction (ALT 3 times greater than upper normal limit)~* Thyreoid insufficiency~* renal artery Stenosis(unilateral \>70％ or bilateral stenosis\>50％)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): perioperative rosuvastatin administration for at least 5 dosages
- control (Type: PLACEBO_COMPARATOR): blank control of perioperative statin administration

Based on this trial design, predict the completion outcome and termination type (if applicable).